Ryan Maynard

Mr. Ryan D.
Maynard, CPA, is a Chief Financial & Accounting Officer at Foghorn Therapeutics, Inc. and an Independent Director at Iovance Biotherapeutics, Inc. He is on the Board of Directors at Iovance Biotherapeutics, Inc. Mr. Maynard was previously employed as a Chief Financial Officer by CARA Therapeutics, Inc., a Chief Financial Officer by Privapath Diagnostics Ltd., a Chief Financial Officer by Blade Therapeutics, Inc., a CFO, Executive VP & Head-Investor Relations by Rigel Pharmaceuticals, Inc., a Controller, Director-Finance & Accounting by Personify, Inc. (California), a Controller by General Magic, Inc., a Senior Manager-Finance by Siliconix, Inc., and a Chief Financial Officer by Paulus (Holdings) Ltd. He received his undergraduate degree from Santa Clara University.